Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 643B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.28% | 336B | |
| -0.86% | +2.79% | +37.72% | +40.85% | 298B | |
| -0.71% | +0.72% | +28.85% | +48.27% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.82% | 222B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| Average | -5.88% | +2.96% | +30.35% | +60.81% | 411.78B | |
| Weighted average by Cap. | -1.16% | +2.71% | +41.37% | +86.55% |
Employees
4
Sector
Pharmaceuticals
Choose MarketScreener 
